Mark H. Paul is President of the Neurovascular division at Stryker. Stryker Neurovascular is a pioneer in the development of technologies for the treatment of Hemorrhagic and Ischemic Stroke. For the past 14 years, Mark has led one of the largest neurosurgery organizations in the world resulting in significant revenue growth and team skillset expansion. Mark has full P&L responsibilities for all operational functions internally along with sales and marketing teams in more than 65 countries around the world. Mark is a 30-year veteran of the Less Invasive Medical Device industry. Over that time, he has led organizations focused on technologies and market development for the less invasive treatment of Neurovascular, Peripheral Vascular and Cardiology, including Peripheral Embolization, Abdominal Aortic Aneurysms and Carotid Intervention. Much of Mark’s career and education has had an international focus including serving as European Director of PV based in Paris, France and VP & GM of International for Boston Scientific Corporation. Mark started his career with Procter & Gamble where he spent 5 years in sales and sales management. Mark graduated from the University of Utah. His education also included time in Selwyn College in Cambridge, England and the Universite de la Neuchâtel in Switzerland. He currently resides in SLC, Utah. He and his wife Jana have 4 children.